100
Participants
Start Date
October 12, 2024
Primary Completion Date
October 31, 2034
Study Completion Date
October 31, 2034
Clinical Research Centre for Rare Diseases Aldo e Cele Daccò, Ranica
Mario Negri Institute for Pharmacological Research
OTHER